- Report
- January 2022
- 70 Pages
Global
From €884EUR$1,000USD£763GBP
- Report
- January 2022
- 90 Pages
Global
From €1768EUR$2,000USD£1,527GBP
- Report
- January 2022
- 150 Pages
Global
From €1326EUR$1,500USD£1,145GBP
- Report
- January 2022
- 125 Pages
Global
From €2210EUR$2,500USD£1,908GBP
- Report
- January 2022
- 90 Pages
Global
From €1768EUR$2,000USD£1,527GBP
- Report
- January 2022
- 90 Pages
Global
From €1768EUR$2,000USD£1,527GBP
- Report
- August 2024
- 136 Pages
Global
From €2652EUR$2,999USD£2,289GBP
- Report
- August 2024
- 149 Pages
Global
From €2652EUR$2,999USD£2,289GBP
- Report
- August 2024
- 137 Pages
Global
From €2652EUR$2,999USD£2,289GBP
- Report
- August 2024
- 143 Pages
Global
From €2652EUR$2,999USD£2,289GBP
- Report
- August 2024
- 141 Pages
Global
From €2652EUR$2,999USD£2,289GBP
- Report
- August 2024
- 140 Pages
Global
From €2652EUR$2,999USD£2,289GBP
- Report
- August 2024
- 138 Pages
Global
From €2652EUR$2,999USD£2,289GBP
- Report
- August 2024
- 135 Pages
Global
From €2652EUR$2,999USD£2,289GBP
- Report
- March 2024
- 138 Pages
Global
From €2652EUR$2,999USD£2,289GBP
- Report
- March 2024
- 147 Pages
Global
From €2652EUR$2,999USD£2,289GBP
- Report
- March 2023
- 350 Pages
Europe
From €2652EUR$2,999USD£2,289GBP
- Report
- October 2024
- 80 Pages
Vietnam
From €3183EUR$3,600USD£2,748GBP
- Report
- July 2022
- 40 Pages
China
From €2829EUR$3,200USD£2,443GBP
- Report
- January 2020
- 30 Pages
China
From €1945EUR$2,200USD£1,679GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more